Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases

Exclusion Criteria

• •Personal history of cancer.
• •Current weight loss treatment (diet, supplementation, surgery, others...).
• •Bariatric surgery.
• •No stable pharmacological treatment for at least 3 months.
• •Diabetes treatment and hormone replacement therapy.
• •Relevant functional or structural abnormalities of the gastrointestinal tract, such as malformations, angiodysplasias, active peptic ulcers, chronic inflammatory or malabsorption diseases, hiatal hernia, chronic reflux, etc.
• •High alcohol intake, more than 14 units per week for women and 20 units per week for men.
• •Surgical interventions resulting in permanent sequelae of the gastrointestinal tract.
• •Liver disease, except for non-alcoholic fatty liver disease.
• •Cognitive and/or psychiatric impairment.
• •Poor compliance or difficulty following study procedures.
• •BREAST CANCER PARTICIPANTS:
• •Luminal subtype breast cancer stages over than II or other type of breast cancer.
• •Require preoperative treatment.